FDA seeks feedback on potential regulatory approaches for generative AI-enabled medical devices
In a new discussion paper, the FDA details potential regulatory approaches for medical devices that use generative artificial intelligence, emphasizing a total product lifecycle perspective. The agency highlights the need for structured oversight of risk classification, premarket submissions, and postmarket surveillance specific to clinical AI technologies.
About LOG Standards
LOG Standards provides an independent accreditation signal for AI models used in healthcare, helping hospitals, care networks, and AI companies bring clinical AI readiness and governance into clearer conversations.
Our AI Intelligence Briefing tracks the latest developments in AI safety, AI in medicine, mental health AI, clinical AI governance, and regulatory policy — keeping healthcare stakeholders informed about the rapidly evolving AI landscape.